Urological practice during COVID-19 pandemic in Târgu Mureș

The elective urological surgeries were canceled or postponed due to the high risk of COVID-19 infection , reduced medical resources and number of beds or limited number of healthcare workers from the hospital. Associated urological pathology was diagnosed in 23(22,54%) of the cases and 79 (77,45%) p...

Full description

Saved in:
Bibliographic Details
Published inRomanian journal of urology Vol. 19; no. 1; pp. 19 - 22
Main Authors Amota, Orsolya, Frunda, Edva Anna, Ghirca, Veronica, Vida, O, Todea, C, Porav-Hodade, D, Balan, D, Brad, A, Martha, Orsolya
Format Journal Article
LanguageEnglish
Published Bucharest Romanian Journal of Urology 01.01.2020
Subjects
Cancer
Catheters
Coronaviruses
COVID-19
Disease transmission
Epidemics
Infections
Laboratories
Medical personnel
Pandemics
Pathology
Patients
Pneumonia
Prostate
Statistical analysis
Surgery
Urology
Asia
China
Africa
Online AccessGet full text

Cover

More Information
Summary:The elective urological surgeries were canceled or postponed due to the high risk of COVID-19 infection , reduced medical resources and number of beds or limited number of healthcare workers from the hospital. Associated urological pathology was diagnosed in 23(22,54%) of the cases and 79 (77,45%) presented no urological disease. 7 patients presented indication for urological procedure: suprapubic cystostomy (1 patient), nephrostomy tube insertion (3 patients), ureteral stent insertion (1 patient), urinary catheter insertion (2 patients) The statistical analysis revealed that there was no statistical correlation between the number of patients diagnosed with SARS COV2 infection and urological patients, p>0,005 (p=0,95.) The surgical practice in urology was limited to emergencies like: urinary tract obstruction, infection, acute renal failure, sepsis, trauma with hemodinamical instable patient. A lot of surgical procedures interventions on patients with urological or onco-urological comorbidities, that are not urgent, are postponed, the oncological treatment in patients with stable cancer beeing delayed, so this can have an impact on short-term progression, can worse the clinical treatment outcomes and/or infuence the mortality rates [11].
ISSN:1842-2187